inotuzumab ozogamicin
3129K4-3301
Phase 3 small_molecule terminated
Quick answer
inotuzumab ozogamicin for Lymphoma, Follicular is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Lymphoma, Follicular
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated